AAA April 2015 – Page 18

Evonik feeds Algal’s series B

Evonik Venture Capital, the corporate venturing unit of speciality chemical developer Evonik Industries, has backed a $7m series B round for US-based biotechnology company Algal Scientific Corporation. The round was led by Formation 8 and featured Independence Equity. In April 2014, Algal obtained a $3m series A round from Evonik, Formation 8 and Independence Equity.… Continue reading Evonik feeds Algal’s series B

Thrasos closes $21m series D

Thrasos Therapeutics, a US-based biotherapeutics company developing treatments for kidney disease, has closed a $21m series D round co-led by SR One, the corporate venturing arm of pharmaceutical company GlaxoSmithKline. BDC Capital, a subsidiary of the Business Development Bank of Canada, co-led the round which will support a Phase 2 clinical trial of a treatment… Continue reading Thrasos closes $21m series D